A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.

Tauopathies are a group of disorders leading to cognitive and behavioral impairment in the aging population. While four-repeat (4R) Tau is more abundant in corticobasal degeneration, progressive supranuclear palsy, and Alzheimer's disease, three-repeat (3R) Tau is the most abundant splice, in P...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Edward Rockenstein, Cassia R Overk, Kiren Ubhi, Michael Mante, Christina Patrick, Anthony Adame, Alejandro Bisquert, Margarita Trejo-Morales, Brian Spencer, Eliezer Masliah
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0121570&type=printable

Similar Items

Retraction Note: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies
by: Edward Rockenstein, et al.
Published: (2025-03-01)

RETRACTED ARTICLE: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies
by: Edward Rockenstein, et al.
Published: (2015-11-01)

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure
by: Edward Rockenstein, et al.
Published: (2014-07-01)

Retraction: A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.
by: PLOS One Editors
Published: (2025-01-01)

RETRACTED ARTICLE: Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5 – implications for dementia with Lewy bodies
by: Cassia R Overk, et al.
Published: (2014-05-01)

Retraction Note: Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5– implications for dementia with lewy bodies
by: Cassia R Overk, et al.
Published: (2025-08-01)

Retraction Notice to “Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy” [Neurobiology of Disease 104 (2017) 85–96]
by: Omar El-Agnaf, et al.
Published: (2025-03-01)

Neuropathological changes and cognitive deficits in rats transgenic for human mutant tau recapitulate human tauopathy
by: Janice C. Malcolm, et al.
Published: (2019-07-01)

Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
by: Tomas Smolek, et al.
Published: (2019-12-01)

Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.
by: Diana L Price, et al.
Published: (2010-11-01)

Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
by: Tomas Smolek, et al.
Published: (2020-02-01)

Anterograde and Retrograde Propagation of Inoculated Human Tau Fibrils and Tau Oligomers in a Non-Transgenic Rat Tauopathy Model
by: Lea Langer Horvat, et al.
Published: (2023-03-01)

Corrigendum to “ Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy Body Disease” [Neurobiology of Disease127 (2019) 163–177]
by: Brian Spencer, et al.
Published: (2024-02-01)

Tauopathy strains differentially replicate in vitro in the presence of mutant tau monomer
by: Christine K. Brown, et al.
Published: (2025-10-01)

Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies
by: Isidro Ferrer, et al.
Published: (2019-05-01)

Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice
by: Brian Spencer, et al.
Published: (2025-10-01)

Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy
by: John David Eun, et al.
Published: (2022-07-01)

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models
by: Michiyo Iba, et al.
Published: (2020-07-01)

Î±-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice
by: Yan-Hui Zhang, et al.
Published: (2018-04-01)

Galectin-3 aggravates microglial activation and tau transmission in tauopathy
by: Jian Jing Siew, et al.
Published: (2024-01-01)

Seeding activity of skin misfolded tau as a biomarker for tauopathies
by: Zerui Wang, et al.
Published: (2024-11-01)

Tau positron emission tomography in tauopathies: A narrative review
by: Hyunjong Lee, et al.
Published: (2023-03-01)

Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
by: Celeste Parra Bravo, et al.
Published: (2024-06-01)

Tau protein profiling in tauopathies: a human brain study
by: Juan Lantero-Rodriguez, et al.
Published: (2024-07-01)

The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition
by: Ghazaleh Eskandari-Sedighi, et al.
Published: (2017-10-01)

Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease
by: Simona Eleuteri, et al.
Published: (2015-02-01)

Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy
by: Sonia Lorena Espíndola, et al.
Published: (2018-04-01)

Tau and tauopathies across primate species: implications for modeling neurodegenerative disorders
by: Julia C. Colwell, et al.
Published: (2025-07-01)

Heterogeneous Tau Oligomers as Molecular Targets for Alzheimer’s Disease and Related Tauopathies
by: Chih Hung Lo
Published: (2022-11-01)

Self-assembly of tau fragments as a key pathologic event in tauopathies
by: Ly Thi Huong Luu Le, et al.
Published: (2024-01-01)

Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies
by: Ilaria Linda Dellarole, et al.
Published: (2024-06-01)

Novel aspects of the phosphorylation and structure of pathological tau: implications for tauopathy biomarkers
by: Taeko Kimura, et al.
Published: (2024-02-01)

RNA binding proteins co-localize with small tau inclusions in tauopathy
by: Brandon F. Maziuk, et al.
Published: (2018-08-01)

Immunotherapy with an antibody against CD1d modulates neuroinflammation in an α-synuclein transgenic model of Lewy body like disease
by: Michiyo Iba, et al.
Published: (2024-04-01)

Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model
by: Jiqing Xu, et al.
Published: (2016-08-01)

Author Correction: Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model
by: Jiqing Xu, et al.
Published: (2025-01-01)

Tauopathies: Calmodulin Regulates Tau Hyperphosphorylation and Its Transformation into Disease-Specific Aggregates
by: Danton H. O’Day
Published: (2025-08-01)

PM2.5 triggers tau aggregation in a mouse model of tauopathy
by: Congcong Liu, et al.
Published: (2024-07-01)

A Novel Phosphorylated Tau Conformer Implicated in the Tauopathy Pathogenesis of Human Neurons
by: Nahid Tofigh, et al.
Published: (2025-04-01)

Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration
by: Moumita Majumder, et al.
Published: (2024-06-01)